A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
Linda Bethea details how the marketer of brands including Oikos and Silk is approaching emerging channels and artificial ...
A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...
A MOTHER has revealed that she has lost 10 and a half stone after using Mounjaro. Becca Banks, a mum-of-one from the UK, ...
As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...
Older people with obesity and overweight require access to proven treatment options and care to improve overall health and reduce other related health care costs. This briefing will feature medical ...
A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.
A MOTHER has revealed that she lost over seven stone in just seven months after taking weight loss drug Mounjaro. Layla Angus ...
A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...
In some ways, Ozempic is presented as part of the anti-diet movement, acknowledging that diets don’t work and medication may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback